New clinical trial for weakened or compromised immune systems
Do you have a weakened immune system? If so, you may be eligible to participate in a clinical trial aimed to help protect people with weaker immunity from contracting COVID-19.
Qualmedica Research, a clinical trial site in Bowling Green and associated with the Western Kentucky Heart and Lung/ Med Center Health Research Foundation, is researching investigational antibodies that may help to protect people with weaker immunity from contracting COVID-19.
You may be eligible to take part in this COVID-19 study if you:
- are 12 years of age or older and have an impaired immune system,
- have not tested positive for COVID-19 or received a COVID-19 vaccine in the past 3 months,
- are currently taking immunosuppressive medicine.
Contact Melinda Joyce, Executive Director of Western KY Heart & Lung / Med Center Health Research Foundation at joycmc@mchealth.net. Or click here to request information about this clinical trial. Providers wanting to discuss the clinical trial on behalf of their patients can contact Qualmedica Research at (270) 904-4334 or email Christy Raymer at Christy.Raymer@QualmedicaResearch.com.